Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company, pioneering treatments for patients with rare and severe skin conditions, today provided an update following the unblinding of clinical ...
Takeda Pharmaceutical Co. announced that its oral psoriasis drug zasocitinib proved safe and effective in late-stage trials, ...
Millions of Medicare Part D enrollees will see substantial out-of-pocket savings as negotiated drug prices take effect in ...
By the authority vested in me as President by the Constitution and the laws of the United States of America, it is hereby ordered: Section 1. Purpose and ...
Japan's Takeda Pharmaceutical said on Thursday its experimental pill for a type of skin disease, developed using artificial intelligence, succeeded in two late-stage studies.
New York, NY – December 16, 2025 – In a landmark advancement in minimally invasive dermatologic surgery, Dr. Cameron Rokhsar, ...
The FDA has granted full approval to rucaparib (Rubraca) for adults with BRCA-mutated metastatic castration-resistant prostate cancer. The decision is based on a confirmatory analysis of a randomized ...
Dr Dana Rizk is Professor of Medicine in the Division of Nephrology at the University of Alabama at Birmingham (UAB) and a VOYXACT VISIONARY Study Investigator and Co-Chair of the Steering Committee.
The diabetes medication semaglutide has recently become a trendy weight loss treatment. But like every drug, there are ...
The results position Takeda, which acquired its therapy in one of the industry’s larger single-drug acquisitions, to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback